Medical insurance negotiations more than "soul bargain"
"Every small group should not be given up" "I hope that you will try again" "It’s really hard, I just felt that my tears fell quickly" … Recently, a medical insurance drug negotiation video is brush on the web, once The quotation, a secondary price, the company represents 8 dismissals, after a half an hour of "taking the saw war", eventually each bottle of medicine is more than 20,000 yuan more than the initial offer, praised by netizens The price of the name is also like some rare patient parents. For the people, the more I must be more responsible. Every game, every minute, is not only for the medical insurance fund "decompression", but also to excellent family members.
"Every small group should not be abandoned" to highlight the country’s concern for rare diseases.
The national medical insurance bureau negotiating representatives have made full performance, which reflects the difficulties of medical insurance drug negotiations, but also reflects the strength and determination of the country to solve the problem of the people’s medication, vividly interpret the "people’s first, life-supreme" concept. Medical insurance drug negotiations are not simple to kill, extruded the reasonable profits of enterprises, but through unreasonable premium and moisture in the drug, enterprises are unaffected. The negotiation representative Zhang Jinni has, except "moving the love", "Xia Zhi, induce the profit" – "If this medicine can enter the medical insurance catalog, the Chinese government is determined by the Chinese government, It’s hard to find such a market. " In front of this "supermarket" in China, once the drug is incorporated into medical insurance, the long-term development of enterprises and brands will be great, and the company has power to seek a balance point in "price" and "quantity", which is the key to the success of negotiations. Just as professionals pointed out, the "not the lowest price, but a reasonable price" pursued by medical insurance negotiations, if the negotiation "bargain" has broken through the range of enterprises, it may cause drugs that cannot enter medical insurance or affect the quality of drugs, and finally Injury or the interests of patients.
Therefore, before the negotiation, the National Medical Insurance Bureau has made a lot of work, revolves around the principle of clinical essential, safe and effective, reasonable price, according to the clinical value, economic value, patient value and social value to perform multi-dimensional value assessment of drugs The trial multi-drug economics experts carry out the "back-to-back" measurement of the same drug according to the 上海浅深998598区别 measurement guide, and improve the accuracy and fairness of the measurement result.
After the preparation, declaration, expert review, negotiation, the results of the results, the results of the national medical insurance drug catalog adjustment results were officially released in 2021.
This adjustment added 74 drugs, precise complement tumors, chronic diseases, anti-infects, rare diseases, women and children, etc.
From the patient burden, compared with the original market price, through negotiation price reduction and medical reimbursement, 2022 can be reduced to more than 30 billion yuan for patients in 2022. At this stage, China’s medical insurance fund is still limited, and the national medical insurance drug catalog adjustment work still adheres to the functional positioning of "Basic"上海后花园私人会所, which is tried to do, but also, and combined with urban and rural residents, the per capita disposable income and other factors. Comprehensively consider the patient’s personal burden to withstand, through the calculation of the price that most patients can be used, and the maximum benefits will benefit the people.
At the same time, close attention to the reasonable drug demand, and focus on the basic medication to ensure the short board. By guiding the use of drugs in the treatment and the drug re-price reduction, the fund space is promoted, and the basic drug guarantee is promoted.
Medical insurance catalog drug adjustment is a systematic project, which must make patients have more widened, and the benefits are greater, but also promote the innovation and development of pharmaceutical industry, and achieve 上海哪里可以约到女孩子 multi-party win-win.
Looking forward to the dynamic adjustment of medical insurance drug catalogs is more stable and farther, which is a real happiness increment for 10 million patients and families.